Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04332939
Other study ID # 2020-3273
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2020
Est. completion date December 2024

Study information

Verified date March 2023
Source Université de Sherbrooke
Contact Guillaume Léonard, PhD. pht
Phone 1 819-780-2220
Email guillaume.leonard2@usherbrooke.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Physical exercises are known to reduce chronic pain in elderly individuals by activating the motor system. However, it seems that exercises are not effective for everyone. The investigators believe that elderly individuals with altered corticospinal tract will be those in whom the exercise alone are not sufficient to relieve pain. For those patients, adding an exogenous stimulation of the motor system such as transcranial direct current stimulation (tDCS) would facilitate the corticospinal tract, and consequently, would help exercises to relieve chronic pain. The investigators hypothesize that combining tDCS with the exercises will be more effective than exercises alone, but only in individuals who initially show low corticospinal projections.


Description:

Prevalence and intensity of chronic pain increases substantially with age. According to several studies, physical exercises are effective to reduce chronic pain in elderly. However, it seems that exercises are not effective for everyone. One of the hypotheses raised is that the people in whom the exercises have no effect would be those with an alteration of the corticospinal tract. Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique known to facilitate the corticospinal tract when applied over the motor cortex. Elderly suffering from chronic pain will be recruited in this double-blind, parallel-group, randomised control trial. Participants will be randomized to receive exercises combined to real tDCS (5 daily sessions, 2 mA, 20 minutes) or to sham tDCS. Intervention will last 8 weeks at a rate of 3 workouts per week.


Recruitment information / eligibility

Status Recruiting
Enrollment 32
Est. completion date December 2024
Est. primary completion date October 1, 2023
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - To have musculoskeletal chronic pain - Not to change medication and life habits during the study Exclusion Criteria: - People physically active before the study (more then 150 min of moderate to vigorous exercise par week) - To have an uncontrolled cardiovascular disease - To have orthopedic limitation or contraindication to physical exercise - To have contraindication to tDCS - To have contraindication to TMS - To have contraindication to MRI

Study Design


Related Conditions & MeSH terms


Intervention

Other:
transcranial direct current stimulation
real tDCS sessions
Physical exercise
Aerobic exercise and physical training combined with sham tDCS

Locations

Country Name City State
Canada Grace Village Sherbrooke Quebec
Canada Research Centre on Aging Sherbrooke Quebec

Sponsors (1)

Lead Sponsor Collaborator
Université de Sherbrooke

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Pain intensity Pain intensity will be assessed with a pain logbook containing a numerical rating scale from 0 to 10 Before intervention (T1), First week of intervention (T2), Week 4 (T3), Week 8 (T4), Follow-up 1 week after intervention (T5), Follow-up 1 month after intervention (T6)
Secondary Corticospinal excitability (TMS) Corticospinal tract excitability will be assessed with transcranial magnetic stimulation (TMS) Before intervention, Follow-up 1 week after, Follow-up 1 month after
Secondary Corticospinal excitability (dMRI) Corticospinal tract excitability will be assessed diffusion magnetic resonance imaging Before intervention, Follow-up 1 week after, Follow-up 1 month after
Secondary Functional connectivity Functional connectivity will be assessed with functional magnetic resonance imaging Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Secondary McGill pain questionnaire McGill pain questionnaire will be used to assess pain in its globality. Score from 0 to 72, higher score means worse outcome. Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Secondary Brief pain inventory Brief pain inventory will be used to assess pain in its globality. Score from 0 to 70, higher score means worse outcome Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Secondary Beck depression inventory Beck depression inventory will be used to assess pain in its globality. Score from 0 to 39, higher score means worse outcome Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Secondary Beck anxiety inventory Beck anxiety inventory will be used to assess pain in its globality. Score from 0 to 63, higher score means worse outcome Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Secondary Margolis pain drawing and scoring system Margolis pain drawing and scoring system will be used to assess pain in its globality. Score from 0 to 45, higher score means worse outcome Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Secondary Patient global impression of change questionnaire patient global impression of change questionnaire will be used to assess pain in its globality. Score from 0 to 18 and a percentage from 0 to 100. Higher scores mean better outcome Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Secondary Tampa questionnaire Tampa questionnaire will be used to assess pain in its globality. Score from 0 to 68, higher score means worse outcome Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Secondary Pain catastrophizing scale Pain catastrophizing scale will be used to assess pain in its globality. Score from 0 to 52, higher score means worse outcome Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain